ALEMBIC PHARMACEUTICALS LTD. - 533573 - Business Responsibility and Sustainability Reporting (BRSR)
Please find attached the BRSR of the Company.18-08-2023
18-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please find attached the intimation under Regulation 30.17-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We would like to inform that the management of the Company shall be meeting analysts/investors through a Road Show hosted by Prabhudas Lilladher Private Limited on 21st August, 2023.16-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Regarding The Letter Received From BSE Limited On 16Th August, 2023 In Relation To Proposed Draft Scheme Of Arrangement Between Alembic Pharmaceuticals Limited ('Company' Or 'APL') And Its Shareholders ('Draft Scheme'), Providing For Reorganization Of General Reserve Of The Company
Please find attached herewith the intimation received from BSE Limited.16-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached intimation for loss of share certificate14-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached the intimation for loss of share certificates for the purpose of claiming the shares from the Investor Education and Protection Fund (IEPF).11-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith the Transcript of the Conference call held on 4th August, 2023.09-08-2023
Reduce Alembic Pharma; target of Rs 705: ICICI Securities
ICICI Securities recommended reduce rating on Alembic Pharma with a target price of Rs 705 in its research report dated August 07, 2023.09-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find the loss intimation received from RTA08-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting analysts/investors through Investec Healthcare & Chemicals conference hosted by Investec Capital Services (India) Private Limited on 11th August, 2023.08-08-2023